CARRARO, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 17.818
EU - Europa 13.926
AS - Asia 7.674
SA - Sud America 1.072
AF - Africa 338
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 7
Totale 40.867
Nazione #
US - Stati Uniti d'America 17.590
CN - Cina 2.962
GB - Regno Unito 2.961
RU - Federazione Russa 2.468
SG - Singapore 2.437
IT - Italia 1.887
IE - Irlanda 1.753
UA - Ucraina 1.141
SE - Svezia 1.019
DE - Germania 939
FR - Francia 912
BR - Brasile 893
VN - Vietnam 585
HK - Hong Kong 570
FI - Finlandia 467
KR - Corea 414
IN - India 201
ZA - Sudafrica 172
CA - Canada 105
BD - Bangladesh 86
MX - Messico 74
ES - Italia 67
TR - Turchia 63
JP - Giappone 59
AR - Argentina 56
PL - Polonia 50
IQ - Iraq 47
NL - Olanda 42
BE - Belgio 41
CZ - Repubblica Ceca 39
PK - Pakistan 38
EC - Ecuador 31
AU - Australia 30
MA - Marocco 26
NG - Nigeria 26
UZ - Uzbekistan 24
CI - Costa d'Avorio 22
ID - Indonesia 22
VE - Venezuela 22
AT - Austria 21
CL - Cile 21
KE - Kenya 21
CO - Colombia 20
EG - Egitto 19
SA - Arabia Saudita 18
AE - Emirati Arabi Uniti 17
TN - Tunisia 17
PH - Filippine 16
JO - Giordania 15
LT - Lituania 15
ET - Etiopia 13
AZ - Azerbaigian 12
NP - Nepal 12
PY - Paraguay 12
HU - Ungheria 11
MY - Malesia 11
RO - Romania 11
CH - Svizzera 10
DO - Repubblica Dominicana 10
DZ - Algeria 10
BO - Bolivia 9
DK - Danimarca 9
JM - Giamaica 9
GR - Grecia 8
KZ - Kazakistan 8
EU - Europa 7
IR - Iran 7
LB - Libano 7
AL - Albania 6
KG - Kirghizistan 6
PT - Portogallo 6
TT - Trinidad e Tobago 6
EE - Estonia 5
IL - Israele 5
LV - Lettonia 5
NO - Norvegia 5
SY - Repubblica araba siriana 5
AM - Armenia 4
BY - Bielorussia 4
NI - Nicaragua 4
OM - Oman 4
PE - Perù 4
TW - Taiwan 4
BG - Bulgaria 3
CG - Congo 3
CR - Costa Rica 3
GT - Guatemala 3
HR - Croazia 3
LU - Lussemburgo 3
MD - Moldavia 3
PR - Porto Rico 3
SC - Seychelles 3
SN - Senegal 3
TH - Thailandia 3
BB - Barbados 2
BH - Bahrain 2
GY - Guiana 2
HN - Honduras 2
MM - Myanmar 2
MN - Mongolia 2
Totale 40.835
Città #
Menlo Park 3.035
Southend 2.657
Dallas 2.055
Dublin 1.743
Singapore 1.380
Chandler 1.078
Ashburn 1.016
Fairfield 1.009
Jacksonville 924
Santa Clara 761
Beijing 749
Moscow 654
San Jose 615
Milan 547
Hong Kong 545
Hefei 472
Wilmington 470
Ann Arbor 452
Woodbridge 440
Seoul 414
Houston 389
Seattle 376
Cambridge 366
Nanjing 333
Siena 329
Princeton 296
The Dalles 249
Los Angeles 230
Helsinki 223
Council Bluffs 205
Rome 193
New York 191
Ho Chi Minh City 186
Lauterbourg 173
Boardman 167
Johannesburg 151
Munich 135
Hanoi 133
Nanchang 107
Buffalo 106
Shanghai 86
San Mateo 83
Orem 79
São Paulo 77
Shenyang 69
Dearborn 67
San Diego 66
Figino 57
Kunming 57
Tianjin 53
Chennai 51
London 51
Changsha 50
Bengaluru 49
Frankfurt am Main 49
Hebei 49
Turku 48
Florence 46
Fremont 44
Jiaxing 43
Tokyo 42
Turin 42
Redondo Beach 40
Redwood City 39
San Francisco 38
Brussels 37
Manchester 37
Dong Ket 36
Düsseldorf 36
Da Nang 35
Warsaw 35
Montreal 34
Norwalk 34
Brooklyn 33
Columbus 33
Málaga 33
Atlanta 31
Jinan 31
Phoenix 31
Toronto 31
Washington 31
Chicago 30
Hangzhou 30
Rio de Janeiro 29
Guangzhou 27
Ningbo 25
Olomouc 25
Venezia 25
Abuja 24
Amsterdam 24
Haiphong 24
Stockholm 24
Izmir 23
Abidjan 22
Renton 22
Tashkent 22
Zhengzhou 22
Belo Horizonte 21
Mexico City 21
Prato 21
Totale 27.928
Nome #
4-Substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof 497
2-Hydroxypropyl-β-cyclodextrin strongly improves water solubility and anti-proliferative activity of pyrazolo[3,4-d]pyrimidines Src-Abl dual inhibitors 409
Adenosine kinase gene expression in human colorectal cancer. 384
Different adaptive responses to hypoxia in normal and multiple myeloma endothelial cells 375
3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors 373
Derives substitues en 4 de pyrazolo[3,4-d]pyrimidine et pyrrolo[2,3-d]pyrimidine et utilisations associees 352
The Shc protein RAI promotes an adaptive cell survival program in hypoxic neuroblastoma cells 335
Novel acylguanidine derivatives targeting smoothened induce antiproliferative and pro-apoptotic effects in chronic myeloid leukemia cells 325
Adaptative cellular responses to hypoxia: role of HIF-1 dependent genes in endothelial cell autophagy and survival 312
Administration of interferons and interleukin 2 via the lymphatic route 311
4-Substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof 308
Human colorectal cancer: gene expression of purine metabolism 307
Carborane-Conjugated 2-Quinolinecarboxamide Ligands of the Translocator Protein for Boron Neutron Capture Therapy 307
N-[2-Methyl-5-(triazol-1-yl)phenyl]pyrimidin-2-amine as a scaffold for the synthesis of inhibitors of Bcr-Abl 307
Analysis of protease-activated receptor-1 and -2 in human scar formation 302
Design, synthesis, biological activity and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization study 300
Short-term hypoxia enhances the migratory capability of dendritic cell through HIF-1α and PI3K/Akt pathway 300
The adaptor protein p66Shc is a positive regulator in the angiogenic response induced by hypoxic T cells 290
Concentrazioni plasmatiche e tissutali di interferone in pazienti sottoposti a resezione chirurgica per cancro polmonare 288
A Ribonuclease Protection Assay-Based Approach for Analysis of Angiogenic Gene Expression in Archival Tissues 284
The Shc protein Rai enhances T-cell survival under hypoxia 280
Cell growth inhibition by interferon in hypoxia 279
Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma 271
Identification of thrombin-like activity in ovarian cancer associated ascites and modulation of multiple cytokine networks 270
Administration of the interferons via the lymphatic route 269
Downregulation of hypoxia-related responses by novel antitumor histone deacetylase inhibitors in MDAMB231 breast cancer cells 268
Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs 266
New 4-substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof 266
Thrombin regulates the expression of pro-angiogenic cytokines via proteolytic activation of protease-activated receptor-1 264
Neuroglobin in Breast Cancer Cells: Effect of Hypoxia and Oxidative Stress on Protein Level, Localization, and Anti-Apoptotic Function 261
The adaptor protein p66shc is a positive regulator in the angiogenic response induced by hypoxic T cells 258
Thrombin-mediated IL-10 up-regulation involves protease-activated receptor (PAR)-1 expression in human mononuclear leukocytes 256
L'ipossia induce l'espressione del recettore attivato da proteasi-1(PAR-1) nelle cellule MDA-MB-231 mediante l'accumulo del fattore indotto dall'ipossia-1alfa 256
Carbonic anhydrase XII expression is linked to suppression of Sonic hedgehog ligand expression in triple negative breast cancer cells 256
Alanine kinetics in humans during low-intensity exercise 255
Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation 251
Hypoxia and immune surveillance: role of the adaptor protein p66ShcA in negative regulation of T-cell activation and survival ' 249
Inhibition of smoothened in breast cancer cells reduces CAXII expression and cell migration 248
Hypoxia Shapes Autophagy in LPS-Activated Dendritic Cells 247
Hypoxia affects dendritic cell survival: Role of the hypoxia-inducible factor-1α and lipopolysaccharide 244
Hedgehog signalling pathway and Carbonic Anhydrases in Breast cancer cell physiology 244
Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype 240
Identification of Hck inhibitors as hits for the development of antileukemia and anti-HIV agents 238
New pyrazolo[3,4-d]pyrimidines endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylation 237
Interleukin 10 production in patients undergoing cardiopulmonary bypass: evidence of inhibition of th-1-type responses 234
Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontin-activated human monocytes 233
Thrombin enhancement of interleukin-1 expression in mononuclear cells: involvement of proteinase-activated receptor-1 232
Inhibition of melanoma cell migration and invasion targeting the hypoxic tumor associated caxii 229
Role of inflammatory mediators in angiogenesis 228
Hypoxia induces the expression and release of interleukin 1 receptor antagonist in mitogen-activated mononuclear cells 227
Pyrazolo[3,4-d]pyrimidines Endowed with Antiproliferative Activity on Ductal Infiltrating Carcinoma Cells 227
Pirazolo[3,4-d]pirimidine come nuovi agenti antiproliferativi. Sviluppo di un modello 3D QSAR a bassa dipendenza conformazionale 226
Distribution of human recombinant interferon-alpha 2 in rat plasma, liver, and experimental liver metastases 226
Pro·angiogenic signaling in neuroblastoma: interplay between HIF-1a and Shc C adaptor protein 224
Comparative proteomic profiling of normal and breast cancer cells under hypoxic conditions. 223
Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma 221
Different expression of cytokines and receptors in bleomycin-sensitive and resistant mice 220
Thrombin inhibits IFN-gamma production in human peripheral blood mononuclear cells by promoting a Th2 profile 219
HIF-1 upregulation by IL-1 contributes to the migratory potential of breast cancer cells 218
The possible role of T cells and neutrophils in the regulation of tumour angiogenesis 218
Regulation of angiogenesis by Th1- and Th2-type cytokines 218
‘HIF-1 dependent adaptative responses to hypoxia: pro-survival and pro-apoptotic signaling pathways 218
Identification of a functional role for the protease-activated receptor-1 in hypoxic breast cancer cells 217
Interferon (IFN) levels in human pulmonary tumors 215
The effects of autologous platelet gel on inflammatory cytokine response in human peripheral blood mononuclear cells 214
Hypoxia induces the expression of protease-activated receptor (PAR)-1 through the hypoxic inducible factor (HIF)-1alpha in breast cancer cells 210
Alpha-thrombin reverses differentiation-related changes in expression of P21CIP1/WAF1 in interferon-gamma differentiated monocytic cells 210
Inhibition of interleukin-12 expression by alpha-thrombin in human peripheral blood mononuclear cells: a potential mechanism for modulating Th1/Th2 responses 209
Human colorectal cancer: upregulation of the adaptor protein Rai in TILs leads to cell dysfunction by sustaining GSK-3 activation and PD-1 expression 207
CA-IX-Expressing Small Extracellular Vesicles (sEVs) Are Released by Melanoma Cells under Hypoxia and in the Blood of Advanced Melanoma Patients 206
Whole body and plasma protein synthesis in exercise and recovery in human subjects 206
Interleukin-1β Affects MDAMB231 Breast Cancer Cell Migration under Hypoxia: Role of HIF-1αand NFκB Transcription Factors 206
Structure-Based Optimization of Pyrazolo[3,4-d]pyrimidines as Abl Inhibitors and Antiproliferative Agents toward Human Leukemia Cell Lines. 205
Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines. 204
Hypoxia affects cytokine production and proliferative responses by human peripheral mononuclear cells 204
Hypoxia triggers autophagy in human monocyte-derived dendritic cells 201
Human alpha-Thrombin Stimulates Proliferation of Interferon-gamma Differentiated, Growth-Arrested, U937 Cells, Overcoming Differentiation-Related Changes in Expression of p21CIP1/WAF1 and Cyclin D1 200
Targeting hypoxia signaling pathways in angiogenesis 199
Urea kinetics in humans at two levels of exercise intensity 199
Hypoxia modulates cyclin and cytokine expression and inhibits peripheral mononuclear cell proliferation 199
Studies for the evaluation of oxygenation and ozonation of blood during extracorporeal circulation 199
Role of p52RAI Shc protein in the adaptive response to hypoxia in T cells 199
Hypoxia induces the expression of protease-activated receptor (PAR)-1 through the hypoxic inducible factor (HIF)-1α in MDA-MB-231 breast cancer cells 198
Role of the hypoxic microenvironment in the antitumor activity of tyrosine kinase inhibitors 198
Hypoxia induces autophagy in human monocyte-derived dendritic cells: involvement of Class III PI3K/VPS34 196
Quantification of incorporation of [15N]ammonia into plasma amino acids and urea 196
p66Shc is involved in promoting HIF-1alpha accumulation and cell death in hypoxic T cells 196
Cytokine expression in bleomycin-sensitive and resistant mice 195
Role of the Hypoxia-Inducible Factor-1alpha and Akt on hypoxia-induced migratory program in dendritic cells 195
The thrombin peptide, TP508, enhances cytokine release and activates signaling events 195
Hypoxia induces coordinated adaptive responses in SK-N-MC neuronal cells towards a pro-angiogenic and migratory phenotype 195
SQSTM1/p62 inhibition impairs pro-survival signaling in hypoxic human dendritic cells 194
Interferon levels in human pulmonary tumors are lower than plasma levels 192
Regulation of the hypoxia-inducible factor (HIF)-1α by interleukin-1: implication for breast cancer cell migration in the tumor microenvironment 192
Regulation of HMG-CoA reductase expression by hypoxia 192
Hypoxia influences the cellular cross-talk of human dermal fibroblasts. A proteomic approach 191
Protease-activated receptor-1 and tumor microenvironment: new insights in the inflammation-tumor progression network 189
Ozonation of human blood induces a remarkable upregolation of heme oxygenase-1 and heat stress protein-70 188
p66Shc promotes apoptosis and antagonises mitogenic signaling in T cells. 186
Inhibition of CAXII impaired melanoma cell migration and invasion under hypoxia 184
Totale 24.461
Categoria #
all - tutte 117.052
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.052


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.194 152 281 121 237 99 36 83 159 124 214 171 517
2022/20233.909 240 255 589 584 385 789 52 284 444 61 139 87
2023/20242.594 102 65 222 121 96 711 911 124 13 31 28 170
2024/20255.092 125 317 486 227 675 223 99 292 405 161 547 1.535
2025/202612.797 943 1.861 1.631 1.341 2.403 401 1.292 399 559 716 214 1.037
2026/2027382 382 0 0 0 0 0 0 0 0 0 0 0
Totale 41.001